The role of growth hormone and IGF-1 in retinopathy: a prospective study of retinopathy in patients with acromegaly and impaired fasting glucose

Table 2 Incidence of retinopathy in patients with acromegaly (n = 91) and impaired fasting glucose (n = 123)

	Acromegaly	Impaired fasting glucose	Odds ratio	95% confidence interval
	n (%)	n (%)	Odds ratio	95% confidence interval
No apparent retinopathy	84 (92.3)	107 (87.0)
Any level of retinopathy	8 (8.8)	12 (9.8)	0.963	0.373–2.485
Non-proliferative retinopathy	7 (7.7)	11 (8.9)	0.830	0.318–2.164
Proliferative retinopathy	3 (3.3)	2 (1.6)	2.461	0.404–14.988

One patient in each group was diagnosed with proliferative retinopathy without diagnosing as no non-proliferative retinopathy during the study period, however they also had other signs of non-proliferative diabetic retinopathy

ISSN: 1758-5996